BioSpace News Archive

Pharm Country

Antares Pharma to Present at the Cowen 42nd Annual Healthcare Conference

Antares Pharma, Inc. today announced that Robert F. Apple, President and Chief Executive Officer, is scheduled to virtually present and host investor meetings at the Cowen 42nd Annual Healthcare Conference being held on March 7-9, 2022.

February 28, 2022

·

4 min read

Business

ICHNOS SCIENCES ANNOUNCES FORMATION OF SCIENTIFIC ADVISORY BOARD TO INFORM RESEARCH AND DEVELOPMENT STRATEGY IN IMMUNO-ONCOLOGY

Ichnos Sciences Inc., a global biotechnology company developing innovative multispecific antibodies for oncology, today announced the formation of its Scientific Advisory Board (SAB) comprised of experts in oncology, immunology, protein engineering, drug discovery and development.

February 28, 2022

·

6 min read

Biotech Beach

Nucleus Biologics Announces Krakatoa™, Aiming to Reinvent the Cell Culture Media Industry

Nucleus Biologics, The Cell Performance Company™, is proud to announce the launch of Krakatoa™, an innovative, first-to-market media maker that will allow researchers to manufacture cell culture media at point of use.

February 28, 2022

·

3 min read

Business

Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs

Alltrna announced the appointment of Anne Pariser, M.D., as Vice President, Medical and Regulatory Affairs.

February 28, 2022

·

4 min read

Pharm Country

ObvioHealth and 1nHealth Launch Initiative to Rescue Clinical Trials Struggling to Transition to Decentralization

ObvioHealth and 1nHealth announce today a joint initiative to smooth the transition to hybrid and decentralized clinical research.

February 28, 2022

·

2 min read

Pharm Country

Akari Therapeutics Announces New Data Showing A Significant Role for Complement Activation in the Clinical Outcomes of U.S. Army Trauma Patients in Iraq and the Therapeutic Potential of Nomacopan for Treatment of Trauma

Akari Therapeutics, Plc (Nasdaq: AKTX), today announced new data showing that clinical outcomes in U.S. Army trauma patients correlate with complement activation, and that nomacopan significantly improves survival from 30% to 80% in a clinically relevant preclinical model of traumatic hemorrhage.

February 28, 2022

·

7 min read

MDimune Signs Research Agreement with YiPSCELL to Develop iPSC-based BioDrone® Therapeutics

MDimune has announced the joint research agreement with YiPSCELL to develop BioDrone® Platform therapeutics based on induced pluripotent stem cells (iPSCs).

February 28, 2022

·

1 min read

Business

Serotiny and Tessera Therapeutics enter into collaboration to engineer and optimize programmable Gene Writer proteins

Serotiny, a leader in high-throughput therapeutic Multi-Domain Protein (tMDP) engineering, and Tessera Therapeutics, a biotechnology company pioneering a new approach in genetic medicines known as Gene Writing technology, today announced a collaboration to engineer programmable Gene Writer proteins.

February 28, 2022

·

4 min read

Pharm Country

Edenbridge Pharmaceuticals Announces the Launch of DARTISLA ODT

Edenbridge Pharmaceuticals, LLC (“Edenbridge”) today announced that DARTISLA ODT (glycopyrrolate) is now available by prescription in the United States through Phil, the commercialization partner and eHub for DARTISLA ODT, as well as in retail pharmacies throughout the country.

February 28, 2022

·

4 min read

Genetown

Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX™ LAAC Device

Boston Scientific Corporation (NYSE: BSX) today announced positive results from a new analysis assessing real-world outcomes with the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device. Presented during a late-breaking trial session at the Cardiovascular Research Technologies (CRT) 2022 meeting.

February 28, 2022

·

5 min read